Helius Medical Technologies, Inc. (HSDT)

USD 0.49

(3.7%)

Market Cap (In USD)

1.81 Million

Revenue (In USD)

644 Thousand

Net Income (In USD)

-8.85 Million

Avg. Volume

225.76 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.373-9.5
PE
-
EPS
-
Beta Value
1.614
ISIN
US42328V8019
CUSIP
42328V504
CIK
1610853
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Dane Carl Andreeff
Employee Count
-
Website
https://heliusmedical.com
Ipo Date
2014-06-27
Details
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.